Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0759
D

Medication Error Rate Exceeds Threshold Due to Improper Administration

Riverton, Wyoming Survey Completed on 06-26-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

During a medication administration observation, an LPN prepared and administered seven medications to a resident, including potassium chloride extended release and duloxetine hydrochloride delayed release. The LPN opened the duloxetine capsule and placed its contents in a medication cup, then crushed the potassium chloride tablet along with other medications before mixing them with applesauce and administering them to the resident. Review of the resident's physician orders indicated that medications could be crushed unless contraindicated, but specifically ordered duloxetine as a delayed release capsule and potassium chloride as an extended release tablet, both of which should not be altered. Manufacturer guidelines for both duloxetine delayed release and potassium chloride extended release specify that these medications should be swallowed whole and not crushed, chewed, or opened. The facility's own policy also states that long-acting, extended release, or enteric coated dosage forms should generally not be crushed, and alternatives should be sought. The medication error rate during this observation was calculated at 7.69%, exceeding the acceptable threshold of 5%.

An unhandled error has occurred. Reload 🗙